Since the emergence of coronavirus disease 19 (COVID-19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS-COV-2), the world has been battling a severe pandemic.
What initially seemed to be only a respiratory tract infection, soon proved to be
a systemic pathology, ranging from asymptomatic to lethal, whose mechanisms of action
involves both inflammatory and thromboembolic processes. The otorhinolaryngological
symptoms most commonly observed for this disease are odynophagia and runny nose, but
changes in smell and taste are commonly associated with COVID-19, suggesting that
the virus may have also involve sensory or neural structures.[1]
In the field of otology, symptoms such as hearing loss, tinnitus and dizziness have
also been related to COVID-19, a fact that had never been described in association
with infections by other coronaviruses, such as Severe Acute Respiratory Syndrome
(SARS) and Middle East Respiratory Syndrome (MERS). Since the start of the pandemic,
reports of sudden deafness and acute vestibular symptoms in patients infected with
SARS-COV-2 have been published.[2]
[3] Performance declines in cochlear implant (CI) users have also been described as
an initial symptom of COVID-19 infection, as well as altered otoacoustic emissions
in infants with intrauterine exposure to the virus.[4]
[5]
Several studies have been conducted in an attempt to clarify the relation between
otologic symptoms and SARS-COV-2 infection; however, the lesser severity of these
symptoms, the difficulty in performing objective tests during the acute phase of the
disease and data collection in a truly representative sample of the population have
interfered with their quality. The real prevalence of hearing loss, tinnitus and dizziness
in patients with COVID-19 is therefore unknown. Özçelik Korkmaz et al.[6] (2021) found a 31.8% prevalence of dizziness, 11% of tinnitus, and 5.1% of hearing
loss in 116 inpatients, while Freni et al.[7] (2020) evaluated 20 outpatients and found onset or worsening of pre-existing hearing
loss and tinnitus in 40% and 20% of cases, respectively.[6]
[7]
Considering the pathophysiology of the disease, mechanisms that could explain the
audio-vestibular symptoms include: direct virus infection causing cochleitis or neuritis
of the VIII cranial nerve; cochleo-vestibular damage secondary to cytokine storm;
ischemic processes or autoimmune dysfunction, caused by cross-reaction of antibodies
or T cells against inner ear antigens.[2]
[3]
[8]
SARS-COV-2 virus enters cells by binding to angiotensin-converting enzyme 2 (ACE2)
receptors. A recent study conducted at the Massachusetts Institute of Technology (MIT)
and Massachusetts Eye and Ear identified that both hair cells and Schwann cells of
the inner ear express ACE2 and two more enzymes, furin and transmembrane protease
serine 2, that help the virus fuse into the host cell. These findings indicate that
direct SARS-COV-2 infection is associated with audio-vestibular dysfunction in COVID-19.[9]
The development of specific vaccines has allowed a significant reduction in the number
of new cases, resulting in a significant decrease in mortality associated with COVID-19.
However, as vaccines do not prevent contamination nor completely protect against infection,
we should consider a diagnosis of COVID-19 for all patients who present with hearing
loss, tinnitus or dizziness without other justifiable causes. Vaccines are essential
to control the pandemic, but cases of sudden deafness, tinnitus, vertigo and facial
paralysis have been reported after their application. However, there are still no
definitive data on the incidence of these symptoms as side effects, as well as whether
the prevalence would be higher for vaccines against SARS-COV-2 than for vaccines against
another virus.[10]
[11]
[12]
[13] Another reason for warning is the emergence of new strains of the virus that are
currently triggering an increase in the number of cases.
It is important to highlight that factors other than the primary infection itself
can generate otoneurologic symptoms, particularly tinnitus and dizziness. The impact
of the pandemic itself, generating stress and anxiety, has been linked to an increase
in the perception of tinnitus.[14] Imbalance and instability are the most frequently encountered forms of dizziness
and seem to be related to metabolic and nutritional dysfunctions due to severe illness
as well as dysautonomia.[15]
Finally, current knowledge suggests that SARS-COV-2 may be responsible for otologic
symptoms.[9]
[16] Despite this, we still need concrete answers about the real prevalence of these
symptoms in patients affected with COVID-19, as well as the mechanisms involved in
this process. A multidisciplinary research group at the Hospital das Clínicas of the
Faculty of Medicine of the University of São Paulo (HCFMUSP) is developing a study
whose first phase investigated a cohort of more than 800 patients between 06 and 11
months after their hospitalization for COVID-19, evaluating several data related to
signs and symptoms of the disease, including hearing loss, tinnitus and dizziness.
We hope that this study can contribute to the answers needed to define specific assessment
and treatment protocols.
